← Back to Search

Behavioural Intervention

Self-Distancing for Obsessive-Compulsive Disorder

N/A

Waitlist Available

Led By Kate D Fitzgerald, MD

Research Sponsored by Columbia University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 3, 4, 5, 6, 7, 8, 9, 10

Awards & highlights

Study Summary

This trial is looking at a technique called Self-Distancing, which involves changing your perspective to a more objective view in emotionally charged situations. The study wants to see if using self-distancing can help

Who is the study for?

This trial is for children with anxiety disorders, OCD, or compulsive personality disorder. It's designed to see if a new way of thinking called self-distancing can help them better handle situations that scare them compared to classic exposure therapy.Check my eligibility

What is being tested?

The study compares two methods: Self-Distancing (EXSD), where kids learn to shift their perspective in scary situations, and Classic Exposure (EXC), the usual way of facing fears directly. Researchers will measure how these techniques affect the children's willingness to face fears and their anxiety levels.See study design

What are the potential side effects?

Since both interventions are psychological strategies rather than medications, they may not have typical 'side effects'. However, participating children might experience increased anxiety or distress temporarily when facing feared situations during therapy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 3, 4, 5, 6, 7, 8, 9, 10

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 3, 4, 5, 6, 7, 8, 9, 10

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 3, 4, 5, 6, 7, 8, 9, 10 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Treatment Engagement and Adherence Ratings (TEARS)

Secondary outcome measures

Anxiety Disorders Interview Schedule for DSM-5 (ADIS) Clinical Severity Rating (CSR)

Other outcome measures

Child Yale-Brown Obsessive-Compulsive Scale (CY-BOCS)

Clinical Global Impression of Improvement (CGI-I) Scale

Clinical Global Impression of Severity (CGI-S) Scale

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Self-DistancingExperimental Treatment1 Intervention

Youth will be randomized to 10 weekly exposure therapy sessions. In the Self-Distanced arm, participants will be instructed to describe exposure tasks from a self-distanced perspective (e.g., "Emily is going to touch the dirty floor").

Group II: Classic ExposureActive Control1 Intervention

Youth will be randomized to 10 weekly exposure therapy sessions. In the Classic Exposure arm, participants will be instructed to describe exposure tasks from a self-immersed perspective (e.g.,"I'm going to touch a dirty floor")

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor

1,431 Previous Clinical Trials

2,460,798 Total Patients Enrolled

5 Trials studying Obsessive-Compulsive Disorder

541 Patients Enrolled for Obsessive-Compulsive Disorder

Kate D Fitzgerald, MDPrincipal InvestigatorProfessor of Psychiatry

1 Previous Clinical Trials

48 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants who are older than 50 years being considered for enrollment in this research study?

"Individuals aged between 7 and 17 years are eligible for enrollment in this research study."

Answered by AI

Is it possible for me to be enrolled as a participant in this medical study?

"To qualify for participation in this research study, individuals must have diagnosed anxiety disorders and fall within the age range of 7 to 17 years. A total of 35 participants will be enrolled in the trial."

Answered by AI

Recent research and studies

European PsychiatryJournal

Patient Centric Measures for a Patient Centric Era: Agreement and Convergent Between Ratings on the Patient Global Impression of Improvement (PGI-I) Scale and the Clinical Global Impressions – Improvement (CGI-S) Scale in Bipolar and Major Depressive Disorder

Mohebbi, M., S. Dodd, O.M. Dean, and M. Berk. 2018. “Patient Centric Measures for a Patient Centric Era: Agreement and Convergent Between Ratings on the Patient Global Impression of Improvement (PGI-I) Scale and the Clinical Global Impressions – Improvement (CGI-S) Scale in Bipolar and Major Depressive Disorder”. European Psychiatry. Cambridge University Press (CUP). doi:10.1016/j.eurpsy.2018.05.006.

clinicaltrials.govStudy

Self-Distancing for Pediatric Anxiety and OCD

Kate D. Fitzgerald, MD 2024. "Self-Distancing for Pediatric Anxiety and OCD". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06339463.

All > Anxiety Disorder > Ocd